---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-141365"
form_type: "8-K"
ticker: "VERU"
cik: "0000863894"
company_name: "VERU INC."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T05:25:06.922850+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Veru Q2 net loss $38.8M ($0.48/share); revenue falls to $6.6M; FDA agrees on sabizabulin Phase 3 design

## Summary
- Net loss $38.8M vs $14.2M YoY; operating loss $39.4M including $3.9M impairment and $3.9M credit loss provision.
- Revenue down to $6.6M from $13.0M; gross profit $4.1M vs $11.2M; R&D expense rose to $22.9M.
- Cash and equivalents $23.5M at March 31, 2023, down from $80.2M at September 30, 2022.
- FDA agreed on confirmatory Phase 3 trial for sabizabulin in COVID-19 ARDS; 408-subject, two interim efficacy analyses planned.
- Sold ENTADFI for $20M plus up to $80M milestones; Lincoln Park Capital committed up to $100M common stock purchase.

## SEC filing metadata
- accession: 0001193125-23-141365
- form_type: 8-K
- ticker: VERU
- cik: 0000863894
- company_name: VERU INC.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/863894/000119312523141365/0001193125-23-141365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/863894/000119312523141365/d466660d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-141365
- JSON: https://secwatch.observer/filing/0001193125-23-141365.json
- Plain text: https://secwatch.observer/filing/0001193125-23-141365.txt

## Key facts
- Earnings Releases
  VERU INC. reported financial results for the quarter and six months ended March 31, 2023.
  - Period: the quarter and six months ended March 31, 2023
  - Result: reported results
  source text: On May 11, 2023, Veru Inc. issued a press release (the "Press Release") announcing results for the quarter and six months ended March 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/863894/000119312523141365/0001193125-23-141365-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.